Episode Summary: In this episode of FDA Imports: Cross-Border compliance with Attorney Benjamin L. England, host Sean O'Connor sits down with Benjamin L. England, a former FDA attorney with over 40 years of experience in FDA, customs, and federal regulatory enforcement. They delve into the intricacies of state Extended Producer Responsibility (EPR) packaging laws, which have taken many food and cosmetic companies by surprise due to recent important deadlines. Ben explains how these laws require producers to manage packaging waste and the penalties for non-compliance. The discussion covers how companies can identify their obligations under these laws, the differences in regulations across states, and the implications for brand owners, manufacturers, and distributors. This episode is essential for businesses navigating the complexities of compliance with state-specific packaging regulations and offers valuable insights into mitigating potential fines and liabilities.

Key Timestamps: 00:01 – Introduction 00:21 – Overview of EPR Packaging Laws 00:50 – Impact on Food and Cosmetic Companies 01:15 – State Registration Requirements 02:39 – Identifying Obligated Producers 04:27 – Differences Across State EPR Laws 07:01 – Business Agreements and Liability 09:33 – State Enforcement and Compliance 11:01 – Reporting and Tonnage Obligations 12:28 – Consequences of Non-Compliance 14:18 – Future of EPR Laws in Other States 16:26 – European Models and Political Influences 17:58 – Steps for Companies to Review EPR Obligations

About the Show: FDA Imports: Cross-Border compliance with Attorney Benjamin L. England is a podcast designed for businesses navigating the complex world of FDA regulations, customs, and federal regulatory enforcement. Hosted by industry experts, the show provides insights into compliance strategies, regulatory updates, and best practices for managing cross-border trade. With a focus on clarity and practical advice, the series aims to empower listeners to make informed decisions and avoid costly compliance pitfalls. Whether you're a seasoned professional or new to the field, FDA Imports: Cross-Border compliance with Attorney Benjamin L. England offers valuable resources and expert perspectives to help you succeed.

For more information, visit our website: https://www.fdaimports.com/

Episode Summary: In this episode of Cross-Border compliance with Attorney Benjamin L. England, host Sean O'Connor and attorney Benjamin L. England delve into the complexities of FDA and customs compliance for importers. Benjamin, a former FDA attorney with over 40 years of experience, explains why FDA approval alone may not shield importers from customs enforcement issues.

The discussion covers historical shifts post-NAFTA, the evolution of inter-agency cooperation, and the critical differences in how FDA and CBP evaluate imports. Benjamin shares insights into common pitfalls importers face, such as handling FDA and customs compliance separately, and offers practical strategies for integrating these processes to mitigate risks. Listeners will gain valuable knowledge on creating a cohesive compliance strategy that addresses both FDA and CBP requirements, ensuring smoother import operations.

Key Timestamps: 00:01 – Introduction 00:38 – Why FDA Approval Isn't Enough 01:47 – Customs and FDA: Different Jurisdictions 03:08 – Pre-NAFTA Compliance Challenges 04:26 – Evolution of FDA and Customs Cooperation 05:06 – Differences in Product Evaluation 07:48 – Shipment Issues Despite FDA Compliance 10:01 – FDA and USDA Regulatory Overlaps 12:10 – Handling FDA and Customs Compliance Separately 14:14 – CBP Discovering Additional Issues 16:24 – Agencies Working Together on Compliance 17:06 – Integrated Compliance Strategy Tips

About the Show: Cross-Border compliance with Attorney Benjamin L. England is a podcast dedicated to helping businesses navigate the intricate world of FDA and customs regulations. Hosted by Sean O'Connor, the show features expert insights from attorney Benjamin L. England and other industry professionals. Each episode breaks down complex regulatory topics, offering practical advice for importers and exporters.

Whether you're a seasoned professional or new to the field, the podcast provides valuable guidance on maintaining compliance and avoiding costly enforcement actions. With a focus on clarity and actionable strategies, Cross-Border compliance with Attorney Benjamin L. England is your go-to resource for Cross-Border compliance

Episode Summary: In this episode of Cross-Border compliance with Attorney Benjamin L. England, host Sean O'Connor and former FDA attorney Benjamin L. England delve into the complexities of tariff refund claims and the resulting customs scrutiny for importers. They discuss the Supreme Court's decision that struck down certain tariffs, leading to a new electronic system, CAPE, designed to facilitate refunds. Despite its implementation, only a small percentage of refunds have been processed, as customs audits and evaluations slow the process.

The conversation highlights the challenges importers face, such as dealing with FDA holds and determining the true party in interest for refunds. England emphasizes the importance of conducting internal audits to ensure compliance and avoid potential penalties. This episode provides valuable insights for importers navigating the intricate landscape of tariff refunds and customs regulations.

Key Timestamps: 00:01 – Introduction 00:07 – Overview of Tariff Refund Claims 00:58 – Supreme Court's Impact on Tariffs 02:16 – Introduction of the CAPE System 03:39 – Challenges in Receiving Refunds 04:52 – Customs' Scrutiny on Past Import Activity 06:34 – Impact of Customs Audits on Refunds 07:04 – When Refund Reviews Become Enforcement Issues 09:05 – Balancing Tariff Refunds with FDA Holds 11:00 – Importer of Record and Refund Claims 12:39 – Civil Disputes Over Refunds 14:52 – Role of Couriers in Refund Claims 16:39 – Litigation Around FDA-Regulated Goods 17:11 – Preparing for Refund Claims: Internal Audits

About the Show: Cross-Border compliance with Attorney Benjamin L. England is a podcast dedicated to providing importers and trade professionals with crucial insights into cross-border compliance. Hosted by Sean O'Connor and featuring expert guests like Benjamin L. England, the show covers a wide range of topics, including FDA regulations, customs enforcement, and international trade laws. With a focus on clarity and practical advice, Cross-Border compliance with Attorney Benjamin L. England aims to help listeners navigate the complex world of import compliance and stay informed about the latest developments in the industry.

Episode Summary:

In this episode, Attorney Benjamin England sheds light on the nuances of voluntary disclosures in FDA and Customs enforcement. He explains the differences between mandatory disclosures in FDA for safety-related issues and the need for prior disclosures in Customs for duty-related matters. The discussion covers scenarios where voluntary disclosures can mitigate risks and instances where they could potentially lead to increased exposure.

Key Timestamps:

00:00 – Introduction: Voluntary Disclosures in FDA and Customs Compliance

00:40 – Key Differences: FDA vs. Customs Disclosure

01:30 – FDA: Importers' Obligation to Report Safety Issues

03:00 – Compliance Responsibility: Importers vs. Manufacturers

04:30 – Increased Compliance for Direct-to-Consumer Imports

05:00 – No Formal Voluntary Disclosure System at FDA

06:00 – Customs: Prior Disclosure for Duty-Related Errors

07:30 – Proactive Reporting Reduces Penalties and Risk

09:00 – Strategic Disclosure Decisions in FDA Cases

10:00 – Customs Disclosure Limits Financial Penalties vs. Duties

11:30 – IRS Analogy: Comparing Customs to Tax Audits

12:30 – When Disclosure May Not Be Necessary

13:30 – Resolving Import Alerts and FDA Detentions

15:00 – High-Risk Customs Issues: Duties and FTAs

16:30 – Customs Investigations: Up to Seven Years of Exposure

17:30 – Factors in Disclosure Decisions: Risk, Exposure, History

18:30 – Global Variations in Compliance Risk Tolerance

19:20 – Conclusion and Key Takeaways

About the Show:

*FDA Imports: Cross-Border compliance with Attorney Benjamin L. England* is a podcast series hosted by Attorney Benjamin England, focusing on cross-border compliance issues in FDA and Customs regulations. The show provides expert insights and guidance for companies navigating the complexities of international trade and regulatory oversight.

Episode Summary:

In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor and attorney Benjamin L. England delve into the complexities of customs post-entry audits, focusing on CF-28s and CF-29s. Benjamin, founder of FDAImports.com and a former FDA regulatory counsel, explains why importers shouldn't assume their responsibilities end once a shipment clears customs. He highlights the importance of understanding the conditional nature of customs releases and the potential for audits years after entry. The discussion covers the differences between CF-28 and CF-29 forms, the types of issues that can trigger audits, and the implications of failing to comply with customs regulations. Benjamin also offers practical advice on maintaining proper documentation and the significance of a well-drafted purchase order to mitigate risks. This episode is essential for importers looking to navigate the intricate landscape of FDA and customs compliance effectively.

Key Timestamps:

00:01 – Introduction

00:07 – Overview of Customs Post-Entry Audits

00:53 – Conditional Release of Goods by Customs

01:58 – Role of FDA in Customs Compliance

03:08 – Customs Examination and Duty Calculation

04:41 – Understanding CF-28 Forms and Compliance

05:48 – Differences Between CF-28 and CF-29

07:42 – Triggers for Post-Entry Audits

10:26 – Record Keeping and Statute of Limitations

12:23 – Importance of Accurate Declarations

14:04 – FDA Involvement in Customs Investigations

16:08 – Systems to Reduce Post-Entry Audit Risks

About the Show:

FDA Imports: Cross-Border Compliance is a podcast designed for businesses navigating the complex world of FDA regulations and international trade. Hosted by industry experts, the show provides insights into compliance strategies, regulatory updates, and best practices for managing cross-border transactions. With a focus on clarity and practical advice, each episode aims to equip listeners with the knowledge they need to successfully import and export goods while adhering to legal requirements. Whether you're a seasoned importer or new to the field, this podcast offers valuable guidance to help you stay compliant and avoid costly pitfalls.

Episode Summary:

In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor is joined by Attorney Benjamin England, founder of FDAImports.com and a former FDA regulatory counsel. They delve into the complexities of first-time FDA-regulated imports, highlighting common mistakes that lead to shipment delays, detentions, or refusals. Benjamin emphasizes the importance of understanding FDA requirements from the outset, including proper documentation and compliance checks before goods leave the foreign supplier. They discuss assumptions that new importers make about FDA requirements, the role of timing in import processes, and the impact of labeling and registration details on shipments. The episode provides valuable insights for businesses entering the US market, offering practical strategies to avoid common pitfalls and ensure smooth import operations.

Key Timestamps:

00:00 – Introduction

00:26 – Common Mistakes in First-Time Imports

01:12 – Importance of Early Transaction Compliance

02:39 – Assumptions About FDA Requirements

03:47 – Challenges with Proprietary Information

05:03 – Role of Customs Brokers

06:01 – FDA's Authority at the Border

07:07 – Labeling and Product Compliance Issues

08:15 – Differing FDA Expectations by Product Type

10:18 – Timing and Its Impact on Imports

12:33 – Perishable Goods and Timing Challenges

14:17 – Case Study: Dietary Supplements

17:08 – Cosmetic Products with Drug Claims

19:18 – Impact of Initial Non-Compliance on Future Imports

About the Show:

FDA Imports: Cross-Border Compliance is a podcast dedicated to helping businesses navigate the intricate world of FDA regulations and international trade. Hosted by industry experts, the show provides insightful discussions on compliance strategies, regulatory updates, and best practices for importing FDA-regulated products. Whether you're a seasoned importer or new to the field, this podcast offers valuable knowledge to ensure your business meets regulatory standards and avoids common pitfalls. With a focus on clarity and practical advice, FDA Imports is your go-to resource for staying informed and compliant in the ever-evolving landscape of cross-border trade.

Episode Summary: In this episode of *FDA Imports: Cross-Border Compliance* Benjamin England delves into the significance of TrumpRX.gov in the context of drug pricing policy and pharmaceutical importation. Exploring the complexities of pharmaceutical pricing disparities between the US and Europe, Ben sheds light on the regulatory changes initiated by the Trump administration to facilitate the importation of pharmaceuticals, offering a potential solution to high drug costs for American consumers.

Key Timestamps: 00:00 – Introduction 02:30 – TrumpRX.gov: A Game-Changer in Pharmaceutical Pricing 06:45 – The Implications of Temporary Programs on Industry Players 10:15 – Enforcement Approaches to Gray Market Rx Drugs 14:50 – Mitigating Risks in Pharmaceutical Importation 18:25 – The Complexities of Regulatory Scrutiny and Sourcing Patterns

About the Show: *FDA Imports: Cross-Border Compliance* provides expert insights into cross-border compliance issues related to FDA regulations and international trade. Led by Attorney Benjamin England, the show navigates the intricate landscape of FDA oversight, regulatory compliance, and importation challenges faced by businesses worldwide.

Episode Summary: In this episode of FDA Imports: Cross Border Compliance with Attorney Benjamin England sheds light on the FDA's recent enforcement discretion around color additives, impacting labeling regulations and creating confusion for importers. He clarifies the distinction between natural and synthetic colors, discusses the FDA's changing approach to artificial colors claims, and outlines the compliance challenges importers may face in light of this guidance.

Key Timestamps: 00:00 – Introduction 02:15 – Differentiating between natural and synthetic colors 04:30 – FDA's enforcement discretion on artificial colors claims 07:45 – Compliance implications for importers 11:20 – Potential risks and considerations for companies 15:00 – Navigating FDA's evolving enforcement expectations

About the Show: *FDA Imports: Cross Border Compliance with Attorney Benjamin England* is the go-to podcast for insights into cross-border compliance issues, hosted by industry expert Benjamin England. Join as the show unravel the complexities of FDA regulations and provide valuable guidance for businesses dealing with import compliance challenges.